New Prognostic Markers for Outcome of Acute Pancreatitis
Authors:
- Athina TatsioniATAthina Tatsioni
- Dimitrios K. ChristodoulouDCDimitrios K. Christodoulou
- Epameinondas V. TsianosETEpameinondas V. Tsianos
- John P. A. IoannidisJIJohn P. A. Ioannidis
- 1 May 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 40 (4) , 522-532
Abstract
The objective of this study was to assess the reporting of studies on new prognostic markers of outcome in acute pancreatitis. We used MEDLINE searches complemented with perusal of review articles' references to identify eligible English-language studies. We included studies evaluating nonroutine markers for acute pancreatitis. Eligible outcomes included Atlanta criteria, Japanese criteria for severity, multiple/single organ failure, complications, interventional treatment, hospitalization length, and death. We generated a 47-item checklist on Acute Pancreatitis Prognosis by adapting a previously constructed reporting guidance instrument for prognostic tumor markers (REMARK [Reporting Recommendations for Tumor Marker Prognostic Studies]). The checklist addresses the reporting of essential information in prognostic studies. The 184 identified eligible studies reported on 196 different prognostic markers. One hundred forty-four studies (78.3%) found at least 1 prognostic marker to be nominally statistically significant. Significant improvements over time were seen in the reporting for 17 items, but major deficiencies were noted even in 2004-2009 studies. Particularly, 12 items were reported in less than 10% of studies overall and even within the most recent studies. Despite some improvements over time, the reporting of important aspects of prognostic studies in acute pancreatitis remains suboptimal. The proposed REMARK-based checklist may help improve the quality and reporting of research in this field.Keywords
This publication has 58 references indexed in Scilit:
- Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery DiseasePLOS Medicine, 2010
- Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelinesBritish Journal of Cancer, 2009
- Criteria for Evaluation of Novel Markers of Cardiovascular RiskCirculation, 2009
- Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysisJNCI: Journal of the National Cancer Institute, 2009
- Translational research: Crossing the valley of deathNature, 2008
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyBMJ, 2008
- REporting recommendations for tumour MARKer prognostic studies (REMARK)British Journal of Cancer, 2005
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- APACHE IICritical Care Medicine, 1985